 diabetes related foot ulcer or gangrene have a
high risk of developing a foot infection or to undergo
one or more (urgent) surgical procedures, it is suggested
for pragmatic reasons that SGLT-2 inhibitors should not
be started in drug na√Øve individuals and that temporary
discontinuation should be considered in those already using these drugs, until the affected foot is healed.
Postscript
The targets discussed in this text are based on reduction of cardiovascular events, but it should be noted